A method for treating cancer comprising the steps of genetically sequencing a patient healthy tissue, genetically sequencing a patient tumor tissue, comparing the genetic sequences of the healthy tissue and tumor tissue to identify one or more mutations specific to the tumor tissue, generating a library of 9-mers having one or more peptide fragments specific to the tumor tissue, and identifying a 9-mer that elicits the strongest immune response in the patient.
